NIMBLE THERAPEUTICS
Nimble Therapeutics is a developer of a drug discovery platform intended to bring the power of massively parallel chemical synthesis to drug discovery. The company uses its unique maskless chemical synthesis platform to synthesize and systematically discover novel medicines in a variety of therapeutic areas, providing customers aid in the empirical optimization of molecules with more favorable drug-like properties.
NIMBLE THERAPEUTICS
Social Links:
Industry:
Biotechnology Chemical Therapeutics
Founded:
2019-01-01
Address:
Madison, Wisconsin, United States
Country:
United States
Website Url:
http://www.nimbletherapeutics.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
10 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Current Employees Featured
Founder
Investors List
Telegraph Hill Partners
Telegraph Hill Partners investment in Series A - Nimble Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-08 | Nimble Therapeutics Appoints Cyrus Arman, PhD, MBA as Chief Business Officer |
Official Site Inspections
http://www.nimbletherapeutics.com Semrush global rank: 3.77 M Semrush visits lastest month: 3.58 K
- Host name: 159.180.132.176
- IP address: 159.180.132.176
- Location: North Chicago United States
- Latitude: 42.325
- Longitude: -87.8561
- Metro Code: 602
- Timezone: America/Chicago
- Postal: 60064
More informations about "Nimble Therapeutics"
Nimble Therapeutics is now part of AbbVie
Our ~50,000 employees around the world focus on discovering and delivering transformational medicines and products.See details»
Nimble Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Nimble Therapeutics is a developer of a drug discovery platform intended to bring the power of massively parallel chemical synthesis to drug …See details»
Nimble Therapeutics - LinkedIn
Nimble Therapeutics is a biotechnology company dedicated to delivering on the promise of oral peptide therapeutics. Leveraging a paradigm-shifting peptide drug discovery and development engine ...See details»
AbbVie to Acquire Nimble Therapeutics, Further Strengthening …
Dec 13, 2024 Proposed acquisition adds Nimble's lead asset, an investigational oral peptide IL23R inhibitor in preclinical development for psoriasis, and a pipeline of other novel oral …See details»
AbbVie Completes Acquisition of Nimble Therapeutics
Jan 23, 2025 Acquisition adds potential novel oral peptide IL23R inhibitor for psoriasis as well as a peptide synthesis, screening and optimization platform to strengthen AbbVie's pipeline and …See details»
Nimble Therapeutics - Overview, News & Similar companies
Nimble Therapeutics has announced that Peter Gough has joined the organization as Chief Scientific Officer. Previously, Gough served as Chief Scientific Officer for Inzen Therapeutics. …See details»
Nimble Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Nimble Therapeutics, Inc. of Madison, WI. Get the latest business insights from Dun & Bradstreet.See details»
AbbVie Acquires Nimble in $200 Million Deal to Strengthen …
Dec 13, 2024 AbbVie has announced plans to acquire Nimble Therapeutics in a $200 million deal. The acquisition brings Nimble’s pioneering oral peptide IL23R inhibitor, currently in …See details»
Nimble Therapeutics - Company Profile - Tracxn
Feb 25, 2025 Nimble Therapeutics - Provider combinatorial chemistry-related drug discovery services. Acquired by AbbVie. Raised a total funding of $10M over 1 round from 2 investors. …See details»
AbbVie to acquire Nimble Therapeutics for $200m - Yahoo Finance
Dec 16, 2024 AbbVie has agreed to acquire Nimble Therapeutics for $200m in cash at closing, subject to standard adjustments, alongside potential interim funding payments.See details»
Head of Biology Nimble Therapeutics, Inc.
Organization covering discovery, validation, and the company’s strategy & portfolio. • Develop the resourcing strategy for the biology and translational needs for internal programs. Provide a …See details»
AbbVie Buying Nimble Therapeutics for $200 Million to
Dec 13, 2024 How we use your personal data How we use your information depends on the product and service that you use and your relationship with us.See details»
Nimble Therapeutics - PitchBook
Nimble Therapeutics General Information Description. Developer of oral peptide therapeutics intended for immune-mediated diseases. The company uses its unique maskless chemical synthesis platform to synthesize and systematically …See details»
AbbVie acquires oral peptide biotech Nimble for $200M
Dec 13, 2024 AbbVie is paying $200 million to snap up Nimble Therapeutics, a Roche spinout working to develop oral peptide treatments in the autoimmune space. | AbbVie is paying $200 …See details»
Partner With Us - Nimble Therapeutics
Challenging Targets Require Novel Solutions Rarely is a successful journey from concept to clinic confined to standard methodologies and off-the-shelf solutions. That is why Nimble Therapeutics was built to be much more than a …See details»
Nimble Announces Formation of a World-Class Scientific Advisory …
MADISON, Wis., June 11, 2024--(BUSINESS WIRE)--Nimble Therapeutics today announced the formation of the Nimble Scientific Advisory Board (SAB) to support the company’s mission to …See details»
Nimble Therapeutics Company Overview, Contact Details
Apr 30, 2019 [email protected]: 50%. See more formats. Frequently Asked Questions Where is Nimble Therapeutics 's headquarters located? Nimble Therapeutics 's …See details»
Nimble Therapeutics - Craft
Nimble Therapeutics has 5 employees at their 1 location and $10 m in total funding,. See insights on Nimble Therapeutics including office locations, competitors, revenue, financials, executives, …See details»
Nimble Therapeutics Company Profile | Management and
[email protected]: Nimble Therapeutics Top Competitors. Company Employees Revenue Top technologies; Varanous Labs Pvt Ltd. 17: $4 M: Redox Scientific. 26: $3.4 M: …See details»
Nimble Therapeutics Delivers Lead Compounds for Two Programs …
MADISON, WI, USA, December 13, 2022 — Nimble Therapeutics Inc., a leading peptide therapeutics company, today announced they have achieved discovery milestones for two …See details»